Clinical Trials Logo

Ganglion Cysts clinical trials

View clinical trials related to Ganglion Cysts.

Filter by:

NCT ID: NCT05600751 Recruiting - Clinical trials for Coronary Artery Disease

Radiosurgery of Ganglion StELlatum In Patients With REFractory Angina Pectoris

RELIEF-AP
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The core hypothesis to be tested is that the radiosurgery of stellate ganglion (left one or both if left-sided without full relief of symptoms) is an effective therapy of refractory angina pectoris in patients with no other therapeutic options - proof of concept study.

NCT ID: NCT05591430 Recruiting - Analgesia Clinical Trials

Pulsed Radiofrequency of S2-4 Versus Ganglion Impar Neurolysis for Severe Perianal and Perineal Pain in Cancer Patients

Start date: October 28, 2022
Phase: N/A
Study type: Interventional

Perineal pain resulting from malignancy is usually severe. Pain can be related to the malignancy or as a complication related to the treatment. several modalities are adopted to control such pain starting from medical management to interventional pain procedures.

NCT ID: NCT05587023 Active, not recruiting - Clinical trials for Possible Molecular Mechanism of Left Stellate Ganglion Block

Effect of Ultrasound-guided Left Stellate Ganglion Block on Rapid Recovery of Patients Undergoing Cardiac Valve Replacement and Its Mechanism

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

In this study, Valve replacement patients undergoing cardiopulmonary bypass were randomly divided into control group and experimental group (SGB Group) , main outcome measures: postoperative complications (pulmonary infection, oxygenation injury, arrhythmia, hemorrhage, enteroparalysis, incision infection, renal insufficiency, cognitive impairment, etc.) and 30-day mortality. Secondary outcome measures: Hemodynamics, postoperative extubation time, length of stay and total cost of hospitalization. To investigate the effect of SGB on the rapid recovery of patients with Valve replacement heart disease after cardiopulmonary bypass.

NCT ID: NCT05513209 Completed - Clinical trials for DECREASE POSTTONSILLECTOMY NAUSEA AND VOMITTING

Opioid Free Pterygopalatine Ganglion Block Based Multimodal Anesthesia for Tonsillectomy Operations

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

intraoperative opioid administration versus intraoperative pterygopalatine ganglion block based opioid free anesthesia to compare outcomes such as postoperative administration of opioid rates of nausea and vomiting, Post Anesthesia Care Unit (PACU) length of stay

NCT ID: NCT05482126 Recruiting - Parkinson Disease Clinical Trials

Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease

Start date: June 8, 2022
Phase:
Study type: Observational

The investigators are investigating the brain activity associated with sensory information in movement disorders in order to improve treatment of these symptoms beyond what is currently available.

NCT ID: NCT05470361 Not yet recruiting - PTSD Clinical Trials

Effects of Stellate Ganglion Block and Superior Cervical Ganglion Block on Sleep and Recovery

Start date: July 2022
Phase:
Study type: Observational

The aim of this study is to discover whether the Stellate Ganglion Block (SGB) plus the Superior Cervical Ganglion Block (SCGB) procedure is associated with improvements in heart rate variability and sleep quality as measured by the Whoop biometric capture device. It is predicted that after receiving the blocks, patients will show objectively improved measures of stress in the form of higher heart rate variability and improved sleep quality as well as improved subjective wellbeing.

NCT ID: NCT05427058 Not yet recruiting - Cervical Cancer Clinical Trials

Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

This study compared the efficacy and safety of superior hypogastric plexus block and ganglion impar block procedures on the management of pelvic and perineal cancer pain in patients with cervical and endometrial cancer

NCT ID: NCT05365880 Recruiting - Stroke Clinical Trials

Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache

Start date: March 23, 2022
Phase: Phase 2
Study type: Interventional

Determine the effects of sphenopalatine ganglion (SPG) block in post-stroke headache.

NCT ID: NCT05301387 Completed - Clinical trials for Post-Dural Puncture Headache

The Effect of Ganglion Sphenopalatine Block (GSP-block) Follow-Up

GSP-FOLLOW
Start date: November 26, 2021
Phase:
Study type: Observational

The purpose of this study is to evaluate the long term effects of the ganglion sphenopalatine block (GSP block) on postdural puncture headache.

NCT ID: NCT05269147 Completed - Clinical trials for Septum; Deviation, Congenital

Lidocaine Versus Bupivacaine for Sphenopalatine Ganglion Block

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The endoscopic septoplasty technique is one of the most frequently performed operations by otolaryngologists throughout the world. It is suggested that 86% of patients who undergo an endoscopic septoplasty would experience pain, and 75% of them suffer moderate to extreme levels of pain. Appropriate management of post-operative pain is a critical component of nasal surgery as it reduces perioperative morbidity, complications, hospital stay, and costs. The sphenopalatine ganglion (SPG) is located in the cranial section of the autonomous nervous system; it is connected with the brain stem and the central nervous system (CNS) and bears unique characteristics favorable for the treatment of many painful syndromes involving the face and head. Sphenopalatine ganglion block (SPGB), along with general anesthesia (GA), is one of the regional anesthetic techniques used to reduce the need for systemic analgesia and provides relative hypotension with controlled heart rate that may lead to a better surgical field for endoscopic surgery. In addition, SPGB appears to shorten hospital stays and reduce narcotic requirements in the recovery area. SPGB with bupivacaine delivered repetitively appears to decreased postoperative pain and more satisfaction with the surgery for patients. Also, Bupivacaine usage in nasal surgery provides better analgesia at least in the first 8 hours period and does not cause more bleeding. On the other hand, SPGB with lidocaine was found to decrease the need for additional analgesics in the postoperative period, increase patient satisfaction, decrease the length of hospital stay, and as a consequence, reduce the rate of secondary infections. However, no previous studies have demonstrated the superiority of one drug over the other when performing an intranasal SPG block. Aim of the work: To determine the efficacy of lidocaine versus bupivacaine for sphenopalatine ganglion block in patients undergoing endoscopic septoplasty.